For People with Purpose by SciPro

What does it take to move from a career in academia into biotech leadership? In this episode of People Behind Progress, Women Building Bio's Gianna Argento sits down with Julie Lin , MD, Senior Vice President of Clinical Development and Drug Safety & Pharmacovigilance at Travere Therapeutics . Julie shares her journey from academic medicine and research into the biotech industry, including...

Welcome to the first episode of HealthTech Happy Hour , part of People Behind Progress by SciPro .Hosted by Lauren Placencia, MD , HealthTech Happy Hour creates space for candid conversations with the founders, clinicians and operators building HealthTech, about what’s working, what isn’t, and what it takes to make meaningful change in healthcare. In this episode, Lauren is joined by Dr. Kate Eise...

We delve into the development of Lucida Medical. Led by long time tech entrepreneur, Dr Antony Rix, he explains how they have grown with purpose and how that has set them apart. This episodes covers Antony’s transition into the world medical devices, how he and the team has continuously solved problems which has led to industry accuracy of their algorithm. And finally the purpose of Antony and Luc...

For People with Purpose is what SciPro stands for. Beats Medical is a purpose-driven DTx startup based in Ireland, working on CNC and other rare diseases, making their technology part of the solution. There is so much to love about this episode, and the crossover between SciPro and Beats Medical is clear to see. We are thankful that Ciara Clancy, the CEO, joined Nick for the penultimate episode of...

We are joined by their CTO, Eric Greveson to hear what has changed since the first episode. It is fair to say a lot has happened for Eric, Brainomix, SciPro and Nick in the last three years. Eric is the CTO of Brainomix. He received his 1st class M.Eng.in Engineering from Cambridge University, and has worked on a wide variety of computer vision projects. These include video processing and 3D graph...

Very rarely do we get a chance to delve into the innovation within large multi national companies. Therefore we are very proud to present the latest episode with Darren Porras, who has spent his career innovating in large medical device companies and continues to support them and smaller start ups in his consulting role. This is a great episode if you are looking for the culture of innovation in d...

After more than 10 years as a powerhouse in DTx it was a pleasure to have Kim join us on the podcast. Kim Baden-Kristensen is the CEO and Co-Founder of Brain+. A company based in Copenhagen that are seeking to meet the challenge of Dementia and Alzheimer's care by harnessing the power of technology and AI. In this episode, we take a deep dive into his career, his purpose and what Brain+ have achie...

LLMs in healthcare. This is the episode we finally tackled the topic in depth. In this episode Nick is joined by the CTO and Co-Founder of Alex Therapeutics, Oliver Fleetwood. Not only do they discuss the technology behind the fantastic Alex product and future products but they tackle the readiness of patients and regulatory bodies for LLMs to be used in mental health care. This is a super excitin...

Building a MedTech start-up with purpose. .. Nick Mahoney is joined by CEO of Sonio, Cecile Dubois. Sonio is an AI-software guiding practitioners during prenatal ultrasound scans to secure prenatal screening and optimize prenatal diagnosis. In this episode, Nick unpacks the technology behind the amazing product and how Cecile has balanced building a diverse company with industry expertise.

In the first episode of series five, host Nick Mahoney was joined by the CCO of Doccla, Tom Breeze. For the first time in our podcast studio, Nick and Tom discuss the transition he made from private equity to healthcare and what drives him about the mission of Doccla. Situated in an exciting period of growth for Doccla, this is great episode to learn more about remote patient monitoring systems an...

In this episode Nick and Jon discuss the future of hiring into Computational Chemistry teams and how the use of AI is affecting this. A topic Nick spoke at great length about at the #aisummit also. Jon has been through many technological changes in the industry and so his expertise and knowledge shines through with some great nuggets of information. Jon Heal is the Silico team (also known as prosa...

Following the successful conclusion of another JP Morgan Conference in 2023, Nick sat down with Dr Juana Candia to hear about her take on this year's conference and what we should take from it. Juana brings more than 20 years of leadership experience in Biotech, Precision Medicine, and Cell & Gene Therapy. She is the co-founder of one of the first Biotech startups in South America, pursued sci...

Focusing on the use of AI in drug discovery, Nick is joined by Quentin Perron; CSO of Iktos. Iktos are a French biotech for ligand-based and structure-based de novo drug design focusing on multi-parametric optimization. Quentin Perron is a medicinal chemist by training. He holds a PhD in organometallic chemistry from the University of Geneva. During his post-doc fellowship at UCLA, he worked on th...

Looking at AI in Drug Discovery begins with a fascinating episode featuring Dr David Wright, CTO and Co-Founder of Kuano. The discussion delved deep into the revolutionary role Kauno is playing in the Drug Discovery process. Dr David Wright is the CTO and Co-Founder of ⁠Kuano⁠, a startup whose mission is to use a unique combination of simulation and AI to bring quantum detail to drug design. By st...

In this episode, Nick and Dr Bouarfa discuss her journey to becoming a CEO, the uniqueness of OKRA.ai and most interestingly the future of female leaders in a STEM subject, particularly within Life Sciences. Dr Loubna Bouarfa is the founder and CEO of ⁠OKRA.ai⁠ - a leading artificial intelligence (AI) company for life sciences, that supports the industry in bringing the right drug to the right pat...

In this awesome episode, Nick discusses with Alex Menys, CEO of Motilent, their current growth and more broadly the state of AI in MedTech. Alex Menys is the CEO of Motilent and his main focus is around measuring treatment response in Crohn's Disease but he is also actively involved in a range of projects around all things gastro including constipation, gastroparesis, IBS and any disease that feat...

In this episode, Nick talks to Albane Grandjean from Gleamer. Gleamer develops medical-grade AI solutions to support radiologists and emergency physicians in their daily work. Their solutions rely on powerful Artificial Intelligence algorithms, to detect and localise lesions on medical images. They have had great success in recent years with their first product, BoneView and they are now working o...

Nick discussed with Sebastian Durandeu from Feebris the transition into MedTech, what to expect when it comes to documentation, and working with ML on the edge. Sebastian is the Head of Software Engineering at Feebris where he leads the software team building the next generation of remote patient monitoring tools using machine learning. He is a software engineer with 10+ years of experience and in...

Earlier in the series, we were honoured to be joined by Dr Tim Guilliams, the CEO and Co-Founder of Healx. Healx have created a suite of AI products and platforms to revolutionise the drug discovery process of rare diseases. It is a truly exciting time for Healx as their first process has reached clinical trials! Tim is a tech entrepreneur from the Cambridge Cluster, passionate about using AI to a...

Nick is joined by Dr.⁠Muhunthan Thillai⁠, the co-founder and CEO of ⁠Qureight⁠ and they discuss the innovative way they are using AI to allow for effective drug development in complex diseases. This is also a fantastic episode for understanding how founders from a medical background have built an AI company. Dr. Muhunthan Thillai is the co-founder and CEO of Qureight, a medical technology company...

In this episode, Nick Mahoney speaks with Dr Mickael Tardy, the CSO from Hera-Mi. This episode is not one to be missed if you are looking to learn about taking risks and the opportunities available in Europe for international learning in software development and especially in medical imaging. Mickael Tardy is a CSO of Hera-MI, a medical imaging software company in Nantes (France), building AI-base...

In this episode, Nick speaks with Lucy Jung, Co-Founder of Charco Neurotech. Charco has created an incredible device that reduces the symptoms of Parkinson’s for patients and helps them live as close to normal lives as possible. Lucy’s passion for bettering the lives of those with Parkison’s is truly infectious, and hopefully, you will all be inspired by this episode. Lucy Jung co-founded Charco N...

In this great episode, Nick speaks with Eva van Rikxoot, CEO of Thirona, and found out about not only the amazing work they do in medical image analysis but also the fantastic approach to hiring they have had from their foundation. This has led them to be a microcosm of the global community for which they serve! Eva van Rikxoort is the founder and CEO of Thirona, an internationally fast-growing co...

In this episode, Nick discusses the incredibly cutting edge world of neural interfaces and the work BIOS is doing to create Neural Digital Therapeutics to help in the treatment of cardiovascular diseases. This incredible episode shows what it takes to be a the forefront of AI research within Life Sciences... This is one not to be missed. Oliver was driven from an early age by a vision that technol...

In this special episode, Nick speaks with both Mark Lynch and Andrii Kulakovskyi to discuss the new BioIT department at Genomic Vision and how they are using AI and Image Processing to aid drug discovery! Andrii established the BioIT department (branch of R&D organisation) working on the development of tools for automated fluorescence image processing and analysis in order to deliver new produ...